Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa

OBJECTIVE: To evaluate the efficacy of ceftazidime-avibactam (CZA) and aztreonam-avibactam (AZA) against bloodstream infections (BSIs) or lower respiratory tract infections (LRTIs) – caused by extensive drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa. METHOD: The two-fold dilut...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yixin, Xie, Lu, Yang, Jiyong, Cui, Junchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338846/
https://www.ncbi.nlm.nih.gov/pubmed/37457958
http://dx.doi.org/10.3389/fcimb.2023.1023948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338846/
https://www.ncbi.nlm.nih.gov/pubmed/37457958
http://dx.doi.org/10.3389/fcimb.2023.1023948

Ejemplares similares